These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 23747745

  • 1. Formulation development of lyophilized, long-term stable siRNA/oligoaminoamide polyplexes.
    Kasper JC, Troiber C, Küchler S, Wagner E, Friess W.
    Eur J Pharm Biopharm; 2013 Oct; 85(2):294-305. PubMed ID: 23747745
    [Abstract] [Full Text] [Related]

  • 2. Development of a lyophilized plasmid/LPEI polyplex formulation with long-term stability--A step closer from promising technology to application.
    Kasper JC, Schaffert D, Ogris M, Wagner E, Friess W.
    J Control Release; 2011 May 10; 151(3):246-55. PubMed ID: 21223985
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG, Mahler HC, Langer K.
    Int J Pharm; 2008 Nov 03; 363(1-2):162-9. PubMed ID: 18672043
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Development of lyophilized gemini surfactant-based gene delivery systems: influence of lyophilization on the structure, activity and stability of the lipoplexes.
    Mohammed-Saeid W, Michel D, El-Aneed A, Verrall RE, Low NH, Badea I.
    J Pharm Pharm Sci; 2012 Nov 03; 15(4):548-67. PubMed ID: 23106958
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
    Chen S, Guo D, Guo B, Liu J, Shen Y, Xu X, Huang W, Guo S.
    Int J Pharm; 2012 May 10; 427(2):145-52. PubMed ID: 22234038
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Formulation, process, and storage strategies for lyophilizates of lipophilic nanoparticulate systems established based on the two models paliperidone palmitate and solid lipid nanoparticles.
    Trenkenschuh E, Savšek U, Friess W.
    Int J Pharm; 2021 Sep 05; 606():120929. PubMed ID: 34303819
    [Abstract] [Full Text] [Related]

  • 12. Excipients for the lyoprotection of MAPKAP kinase 2 inhibitory peptide nano-polyplexes.
    Mukalel AJ, Evans BC, Kilchrist KV, Dailing EA, Burdette B, Cheung-Flynn J, Brophy CM, Duvall CL.
    J Control Release; 2018 Jul 28; 282():110-119. PubMed ID: 29709529
    [Abstract] [Full Text] [Related]

  • 13. Freeze drying of L-arginine/sucrose-based protein formulations, part I: influence of formulation and arginine counter ion on the critical formulation temperature, product performance and protein stability.
    Stärtzel P, Gieseler H, Gieseler M, Abdul-Fattah AM, Adler M, Mahler HC, Goldbach P.
    J Pharm Sci; 2015 Jul 28; 104(7):2345-58. PubMed ID: 25994980
    [Abstract] [Full Text] [Related]

  • 14. Effect of lyophilization and freeze-thawing on the stability of siRNA-liposome complexes.
    Yadava P, Gibbs M, Castro C, Hughes JA.
    AAPS PharmSciTech; 2008 Jul 28; 9(2):335-41. PubMed ID: 18431646
    [Abstract] [Full Text] [Related]

  • 15. Freeze-dried formulations for in vivo gene delivery of PEGylated polyplex micelles with disulfide crosslinked cores to the liver.
    Miyata K, Kakizawa Y, Nishiyama N, Yamasaki Y, Watanabe T, Kohara M, Kataoka K.
    J Control Release; 2005 Dec 05; 109(1-3):15-23. PubMed ID: 16298011
    [Abstract] [Full Text] [Related]

  • 16. Product and process understanding to relate the effect of freezing method on glycation and aggregation of lyophilized monoclonal antibody formulations.
    Awotwe-Otoo D, Agarabi C, Read EK, Lute S, Brorson KA, Khan MA.
    Int J Pharm; 2015 Jul 25; 490(1-2):341-50. PubMed ID: 25835267
    [Abstract] [Full Text] [Related]

  • 17. Impact of dextran on thermal properties, product quality attributes, and monoclonal antibody stability in freeze-dried formulations.
    Haeuser C, Goldbach P, Huwyler J, Friess W, Allmendinger A.
    Eur J Pharm Biopharm; 2020 Feb 25; 147():45-56. PubMed ID: 31866444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lyophilisation and concentration of chitosan/siRNA polyplexes: Influence of buffer composition, oligonucleotide sequence, and hyaluronic acid coating.
    Veilleux D, Gopalakrishna Panicker RK, Chevrier A, Biniecki K, Lavertu M, Buschmann MD.
    J Colloid Interface Sci; 2018 Feb 15; 512():335-345. PubMed ID: 29080529
    [Abstract] [Full Text] [Related]

  • 20. Formulation approach for the development of a stable, lyophilized formaldehyde-containing vaccine.
    Clausi A, Chouvenc P.
    Eur J Pharm Biopharm; 2013 Oct 15; 85(2):272-8. PubMed ID: 23673385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.